OMER : Analysis & Opinions

  1. Every Biotech Catalyst Wedbush Is Watching In 2016

    January 2, 2016
    In a new report, Wedbush analyst Liana Moussatos breaks down potential 2016 catalysts for every emerging pharmaceuticals ...
  2. Omeros Corporation's Stock Surges

    August 20, 2015
    Omeros Corporation (OMER), a Seattle-based biopharmaceutical company, reported an additional positive data from a Phase 2 ...
  3. Four Key Pharmaceuticals ETFs To Consider

    March 25, 2015
    ETF funds are now very liquid investments and are suitable to investors who seek to match the price performance of the indexes ...
  4. The Worst IPOs Of 2009

    December 16, 2009
    The worst initial public offerings in 2009 were in a variety of different industries, and prove once again that stockpicking ...
Trading Center